Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
328 CHF | -1.20% | -1.50% | +8.42% |
Apr. 16 | Ypsomed Partners with ten23 health for Wearable Injector Product Commercialization | MT |
Apr. 12 | Dental Equipment Company Straumann Names New Chair | MT |
Business Summary
Number of employees: 2,200
Sales per Business
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Ypsomed Delivery Systems
61.9
%
| 259 | 55.7 % | 308 | 61.9 % | +18.83% |
Ypsomed Diabetes Care
34.9
%
| 187 | 40.3 % | 174 | 34.9 % | -7.45% |
Other
3.2
%
| 18 | 3.9 % | 16 | 3.2 % | -11.98% |
Sales per region
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Europe
62.1
%
| 297 | 63.8 % | 309 | 62.1 % | +4.13% |
Rest of the World
17.7
%
| 85 | 18.2 % | 88 | 17.7 % | +3.99% |
Switzerland
12.2
%
| 42 | 9.1 % | 61 | 12.2 % | +43.31% |
North America
8.0
%
| 41 | 8.9 % | 40 | 8.0 % | -3.35% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Simon Michel
CEO | Chief Executive Officer | 47 | 06-09-30 |
Frank Mengis
COO | Chief Operating Officer | 60 | 15-09-30 |
Thomas Kutt
IRC | Investor Relations Contact | - | - |
Nicolas Meyer
LAW | General Counsel | 53 | 23-04-30 |
Michael Zaugg
PRN | Corporate Officer/Principal | 52 | 17-03-31 |
Ulrike Bauer
PRN | Corporate Officer/Principal | 55 | 03-12-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Paul R. Fonteyne
BRD | Director/Board Member | 63 | 17-12-31 |
Director/Board Member | 54 | 18-12-31 | |
Chairman | 60 | 20-06-30 | |
Simon Michel
CEO | Chief Executive Officer | 47 | 06-09-30 |
Director/Board Member | 48 | 20-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 13,649,739 | 3,561,306 ( 26.09 %) | 1,000 ( 0.007326 %) | 26.09 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
YPSOMED HOLDING AG 0.14% | 18,721 | 0.14% | 6,715,596 $ |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.57% | 5B | |
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.67% | 40.7B | |
+24.51% | 32.25B | |
+3.43% | 26.53B | |
+14.73% | 25.02B |
- Stock Market
- Equities
- YPSN Stock
- Company Ypsomed Holding AG